Vitamin D supplementation in obese type 2 diabetes subjects in Ajman, UAE: a randomized controlled double-blinded clinical trial

• Published in: European journal of clinical nutrition Vol. 69; no. 6; pp. 707 - 711
• Main Authors: Sadiya, A, Ahmed, S M, Carlsson, M, Tesfa, Y, George, M, Ali, S H, Siddieg, H H, Abusnana, S
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 01.06.2015; Nature Publishing Group
• Subjects: 692/699; Adult; Alfacalcidol; Blood pressure; Body Mass Index; Calcifediol; Calcifediol - blood; Care and treatment; Cholecalciferol - administration & dosage; Cholecalciferol - adverse effects; Cholecalciferol - therapeutic use; Clinical Nutrition; Diabetes; Diabetes Mellitus, Type 2 - complications; Diabetes therapy; Dietary supplements; Dietary Supplements - adverse effects; Double-Blind Method; Epidemiology; Female; Glycated Hemoglobin A - analysis; Health aspects; Humans; Hyperparathyroidism, Secondary - epidemiology; Hyperparathyroidism, Secondary - etiology; Hyperparathyroidism, Secondary - prevention & control; Incidence; Internal Medicine; Lipids; Lost to Follow-Up; Male; Medicine; Medicine & Public Health; Metabolic Diseases; Metabolism; Methods; Middle Aged; Obesity; Obesity - complications; Original; original-article; Overweight persons; Parathyroid Hormone - blood; Patient Dropouts; Public Health; Thyroid; Type 2 diabetes; United Arab Emirates - epidemiology; Vitamin D; Vitamin D Deficiency - blood; Vitamin D Deficiency - complications; Vitamin D Deficiency - drug therapy; Vitamin D Deficiency - physiopathology; United Arab Emirates

Objectives: To study the effect of Vitamin D 3 supplementation on metabolic control in an obese type 2 diabetes Emirati population. Methods: This randomized double-blind clinical trial was conducted with 87 vitamin D-deficient obese, type 2 diabetic participants. The vitamin D-group ( n =45) and the...